Toshio Hirozane

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
During the search for orally effective inotropic agents to replace or supplement digitalis glycoside in the management of heart failure, one quinolinone derivative, vesnarinone, was developed in Japan [1,2]. Vesnarinone exerts cardiotonic effects through increasing intracellular cyclic adenosine monophosphate (AMP) by inhibition of a specific isoform of(More)
  • 1